Co-Diagnostics, Inc. Other Income and Expense
Co-Diagnostics, Inc. (CODX) reported Other Income and Expense of -$63.84 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-13
- Co-Diagnostics, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was -$63.84K, a 118.78% decline year-over-year.
- Co-Diagnostics, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was $68.89K, a 93.32% decline year-over-year.
- Co-Diagnostics, Inc. nonoperating income (expense) for the quarter ending 2025-12-31 was $322.34K, a 62.85% decline year-over-year.
- Co-Diagnostics, Inc. nonoperating income (expense) for the quarter ending 2025-09-30 was -$39.57K, a 107.06% decline year-over-year.
- Co-Diagnostics, Inc. nonoperating income (expense) for fiscal 2025 was $1.65M, a 33.85% decline from fiscal 2024.
- Co-Diagnostics, Inc. nonoperating income (expense) for fiscal 2024 was $2.50M, a 45.61% decline from fiscal 2023.
- Co-Diagnostics, Inc. nonoperating income (expense) for fiscal 2023 was $4.60M, a 43.49% decline from fiscal 2022.
- Co-Diagnostics, Inc. nonoperating income (expense) for fiscal 2022 was $8.13M.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$63.84K 10-Q · filed 2026-08-13 | $5.06K 10-Q · filed 2026-08-13 | $327.40K derived: sum of 3 quarters · filed 2026-08-13 | $287.83K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $68.89K 10-Q · filed 2026-05-14 | $391.24K derived: sum of 2 quarters · filed 2026-05-14 | $351.67K derived: sum of 3 quarters · filed 2026-05-14 | $691.64K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $322.34K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $282.77K derived: sum of 2 quarters · filed 2026-03-31 | $622.75K derived: sum of 3 quarters · filed 2026-08-13 | $1.65M 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$39.57K 10-Q · filed 2025-11-13 | $300.41K derived: sum of 2 quarters · filed 2026-08-13 | $1.33M 10-Q · filed 2025-11-13 | $2.20M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $339.97K 10-Q · filed 2026-08-13 | $1.37M 10-Q · filed 2026-08-13 | $2.24M derived: sum of 3 quarters · filed 2026-08-13 | $2.80M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $1.03M 10-Q · filed 2026-05-14 | $1.90M derived: sum of 2 quarters · filed 2026-05-14 | $2.46M derived: sum of 3 quarters · filed 2026-05-14 | $2.56M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $867.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.43M derived: sum of 2 quarters · filed 2026-03-31 | $1.53M derived: sum of 3 quarters · filed 2026-03-31 | $2.50M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $560.67K 10-Q · filed 2025-11-13 | $661.90K derived: sum of 2 quarters · filed 2025-11-13 | $1.63M 10-Q · filed 2025-11-13 | $2.61M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $101.23K 10-Q · filed 2025-08-14 | $1.07M 10-Q · filed 2025-08-14 | $2.05M derived: sum of 3 quarters · filed 2025-08-14 | $2.89M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $970.11K 10-Q · filed 2025-05-08 | $1.95M derived: sum of 2 quarters · filed 2025-05-08 | $2.79M derived: sum of 3 quarters · filed 2025-05-08 | $3.63M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $982.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $1.82M derived: sum of 2 quarters · filed 2025-03-27 | $2.66M derived: sum of 3 quarters · filed 2025-03-27 | $4.60M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $840.18K 10-Q · filed 2024-11-07 | $1.68M derived: sum of 2 quarters · filed 2024-11-07 | $3.61M 10-Q · filed 2024-11-07 | $4.69M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $837.29K 10-Q · filed 2024-08-08 | $2.77M 10-Q · filed 2024-08-08 | $3.85M derived: sum of 3 quarters · filed 2024-08-08 | $6.91M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | $1.94M 10-Q · filed 2024-05-09 | $3.01M derived: sum of 2 quarters · filed 2024-05-09 | $6.07M derived: sum of 3 quarters · filed 2024-05-09 | $6.79M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $4.14M derived: sum of 2 quarters · filed 2024-03-14 | $4.86M derived: sum of 3 quarters · filed 2024-03-14 | $8.13M 10-K · filed 2024-03-14 | $8.13M 10-K · filed 2023-03-16 |
| 2022-09-30 | $3.06M 10-Q · filed 2023-11-09 | $3.78M derived: sum of 2 quarters · filed 2023-11-09 | $7.06M 10-Q · filed 2023-11-09 | $6.99M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $719.23K 10-Q · filed 2023-08-10 | $4.00M 10-Q · filed 2023-08-10 | $3.93M derived: sum of 3 quarters · filed 2023-08-10 | $3.88M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $3.28M 10-Q · filed 2023-05-11 | $3.21M derived: sum of 2 quarters · filed 2023-05-11 | $3.16M derived: sum of 3 quarters · filed 2023-05-11 | $3.30M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$64.43K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$118.00K derived: sum of 2 quarters · filed 2023-03-16 | $21.13K derived: sum of 3 quarters · filed 2023-03-16 | -$429.16K 10-K · filed 2023-03-16 | |
| 2021-09-30 | -$53.56K 10-Q · filed 2022-11-10 | $85.56K derived: sum of 2 quarters · filed 2022-11-10 | -$364.72K 10-Q · filed 2022-11-10 | -$581.34K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $139.12K 10-Q · filed 2022-08-11 | -$311.16K 10-Q · filed 2022-08-11 | -$527.77K derived: sum of 3 quarters · filed 2022-08-11 | $250.78K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$450.29K 10-Q · filed 2022-05-12 | -$666.90K derived: sum of 2 quarters · filed 2022-05-12 | $111.65K derived: sum of 3 quarters · filed 2022-05-12 | $408.38K derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$216.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $561.94K derived: sum of 2 quarters · filed 2022-03-24 | $858.67K derived: sum of 3 quarters · filed 2022-03-24 | $875.42K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $778.55K 10-Q · filed 2021-11-12 | $1.08M derived: sum of 2 quarters · filed 2021-11-12 | $1.09M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $296.73K 10-Q · filed 2021-08-12 | $313.49K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $16.76K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$301.82K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |